ACC together with AHA and other key healthcare organizations, has launched "Door to Balloon (D2B): An Alliance for Quality." A Guidelines Applied in Practice (GAP) Program, the D2B campaign is aimed at improving the timeliness of lifesaving therapy for patients with heart attacks at the nation's hospitals that perform emergency angioplasty.
Cabrini Medical Center of New York City and University of California, Irvine (UCI) Cardiovascular Imaging Center, have ...
The diagnostic tools are in place, but the connection between imaging machines and data management systems needs to be tighter if cardiovascular practices are going to keep up with the ever-growing patient volume, experts at Siemens Medical Solutions said from the American Heart Association's (AHA) Scientific Sessions.
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Toshiba America Medical Systems, Inc. held a grand opening Wednesday of the new Toshiba Education Center, a $6 million ...
Medtronic, Inc. has the FDA’s approval to initiate the Feasibility of the Lone Atrial Fibrillation Clinical Trial (FACT) ...
An initial review of the premarket approval application for the ATS 3f(R) Aortic Bioprosthesis Heart Valve has been ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Thoratec has announced it has filed the first two modules of its Pre-Market Approval to market its HeartMate II for ...
The first patient of the PATRIOT (Peripheral Approach To Recanalization In Occluded Totals) U.S. pivotal study has been ...
New tachycardia software for the Merlin Patient Care System by St. Jude Medical has received FDA approval. The software ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
The American College of Cardiology Foundation’s National Cardiovascular Data Registry (NCDR) says it will launch a new ...
San Francisco-based McKesson announced it has agreed to purchase Per-Se Technologies, Alpharetta, Ga., in a deal worth $1.8 billion. The purchase is expected to close in the first quarter of 2007 if it meets regulatory approval.
Stereotaxis has received FDA 510(k) clearance for its Niobe magnetic navigation system for use in neurovascular and ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
An aspirin a day really does keep heart attack and stroke away for women, yet fewer than half of American women who could benefit from the simple measure do not take a daily pill, according to recent research.
The FDA has cleared Boston Scientific’s NexStent Carotid Stent and Monorail Delivery System for use in patients with ...
The FDA has approved NitroMist (Nitroglycerin Lingual Aerosol) for acute relief of an attack or acute prophylaxis of ...
November 12, 2006
